Harvard Stem Cell Institute-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Harvard Stem Cell Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013950
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Harvard Stem Cell Institute (HSCI), a subsidiary of Harvard University is a healthcare institute that conducts research on advance stem cell science using stem cell biology to develop new treatments and cures for disease. The institute provides research programs such as disease programs, core facilities, early-stage research, MD and PhD fellowship, and internship program. It undertakes various disease research programs, which include blood program, cardiovascular program, cancer program, diabetes program, kidney program, nervous system diseases program, and translation research program. The institute also offers clinical trial services. HSCI is headquartered in Cambridge, Massachusetts, the US.

Harvard Stem Cell Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Thrive Bioscience and Harvard Stem Cell Institute Enter into Agreement 10
Boehringer Ingelheim Enters into Research Agreement with Harvard Stem Cell Institute 11
AstraZeneca Enters into Research Agreement with Harvard Stem Cell Institute 12
Evotec Enters Into Research Agreement With Harvard Stem Cell Institute For Amyotrophic Lateral Sclerosis 13
Harvard Stem Cell Institute – Key Competitors 14
Harvard Stem Cell Institute – Key Employees 15
Harvard Stem Cell Institute – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Government and Public Interest 17
Aug 04, 2016: Researchers from CSI Singapore discover new way to inhibit development of lung cancer 17
Jun 06, 2016: New approach could make bone marrow transplants safer 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Key Facts 2
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Harvard Stem Cell Institute, Deals By Therapy Area, 2011 to YTD 2017 8
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Thrive Bioscience and Harvard Stem Cell Institute Enter into Agreement 10
Boehringer Ingelheim Enters into Research Agreement with Harvard Stem Cell Institute 11
AstraZeneca Enters into Research Agreement with Harvard Stem Cell Institute 12
Evotec Enters Into Research Agreement With Harvard Stem Cell Institute For Amyotrophic Lateral Sclerosis 13
Harvard Stem Cell Institute, Key Competitors 14
Harvard Stem Cell Institute, Key Employees 15

★海外企業調査レポート[Harvard Stem Cell Institute-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Merz Pharma GmbH & Co KgaA:医療機器:M&Aディール及び事業提携情報
    Summary Merz Pharma GmbH & Co KgaA (Merz Pharma) is an aesthetics and neurotoxin company that develops products for aesthetic and medical dermatology and neurological movement disorders. The company’s products include aesthetics, ethical drugs, over-the-counter drugs, neurology, and central nervous …
  • Genisphere LLC-製薬・医療分野:企業M&A・提携分析
    Summary Genisphere LLC (Genisphere) is a nanotechnology company which provides DNA-based targeted drug delivery solutions. The company utilizes its proprietary 3DNA platform which enables the application in gene delivery, biologics, small molecules, and RNAi therapuetics. It develops pipeline produc …
  • Denka Co Ltd (4061):企業の財務・戦略的SWOT分析
    Denka Co Ltd (4061) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • AstraZeneca UK Ltd-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca UK Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc is a provider of asthma treatment solutions. The company offers research and develops various novel and targeted medicines. It offers its medicines in therapeutic areas which include cardiovascular; oncology, respiratory, infl …
  • Bio Techne Corp (TECH)-製薬・医療分野:企業M&A・提携分析
    Summary Bio Techne Corp (Bio Techne), develops manufactures and sells biotechnology products and instruments for research and clinical diagnostics. The company provides proteins and antibodies, and related immunoassays and other reagents for research under brands such as R&D Systems, Novus, Biologic …
  • Berkshire Hathaway Energy Co:電力:M&Aディール及び事業提携情報
    Summary Berkshire Hathaway Energy Company (BHE) a subsidiary of Berkshire Hathaway Inc., generates, transmits, stores, distributes, and supplies electricity; and procures, transports, distributes and sells natural gas through its subsidiaries. It generates power through diversified energy sources su …
  • Karachaganak Petroleum Operating BV:企業の戦略的SWOT分析
    Karachaganak Petroleum Operating BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Rafako SA (RFK):企業の財務・戦略的SWOT分析
    Rafako SA (RFK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • AIM Health Group Inc:企業の戦略的SWOT分析
    AIM Health Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Jura Energy Corp (JEC):企業の財務・戦略的SWOT分析
    Jura Energy Corp (JEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Spectrum Brands Holdings Inc:企業の戦略的SWOT分析
    Spectrum Brands Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • REV Group Inc (REVG):企業の財務・戦略的SWOT分析
    REV Group Inc (REVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Tactical Missiles Corporation:企業の戦略・SWOT・財務情報
    Tactical Missiles Corporation - Strategy, SWOT and Corporate Finance Report Summary Tactical Missiles Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Land Securities Group Plc:企業のM&A・事業提携・投資動向
    Land Securities Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Land Securities Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Fusion Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Fusion Pharmaceuticals Inc (Fusion Pharmaceuticals) is a clinical-stage biopharmaceutical company which develops targeted alpha-particle radio therapeutics for the treatment of chemotherapy resistant cancers. Its pipeline product includes FPX-01, a radiolabeled antibody designed to internali …
  • Synopsys Inc (SNPS):企業の財務・戦略的SWOT分析
    Synopsys Inc (SNPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Manulife Financial Corporation:企業のM&A・事業提携・投資動向
    Manulife Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Manulife Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • SOLX Inc-医療機器分野:企業M&A・提携分析
    Summary Solx Inc (SOLX) is a medical device company that develops therapeutic products. The company provides glaucoma surgery devices and treatments for glaucoma therapy. Its SOLX gold shunt is a minimally invasive device, which is used in surgical treatment of glaucoma. SOLX’s product is a gold imp …
  • Sarku Japan:企業の戦略・SWOT・財務情報
    Sarku Japan - Strategy, SWOT and Corporate Finance Report Summary Sarku Japan - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Naturgy Energy Group SA:企業の戦略・SWOT・財務情報
    Naturgy Energy Group SA - Strategy, SWOT and Corporate Finance Report Summary Naturgy Energy Group SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆